ANIP financials
ANI Pharmaceuticals (ANIP) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ANIP income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $883.37M | $450.64M | $81.23M | $78.34M | 3.32 |
| 2024 | $614.38M | $364.17M | $584.00K | -$18.52M | -1.04 |
| 2023 | $486.82M | $305.30M | $46.97M | $18.78M | 0.94 |
| 2022 | $316.38M | $177.60M | -$35.28M | -$47.90M | -3.05 |
| 2021 | $216.14M | $115.53M | -$39.79M | -$42.60M | -3.40 |
| 2020 | $208.47M | $121.32M | -$16.02M | -$22.55M | -1.88 |
- ANIP revenue was $883.37M in fiscal 2025, net income $78.34M.
Updated 2026-11-03 02:02 UTC